Brief: Immunome Reports Fourth Quarter And Full Year 2022 Financial Results

Immunome

16/03/2023 12:42

March 16 (Reuters) - Immunome Inc  IMNM.O :
    * IMMUNOME REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS
    * IMMUNOME INC - AS OF DECEMBER 31, 2022 CASH AND CASH
EQUIVALENTS
TOTALED $20.3 MILLION
    * IMMUNOME INC - NET LOSS ATTRIBUTABLE TO COMMON
STOCKHOLDERS WAS
$7.8 MILLION, OR $0.64 PER SHARE, FOR THREE MONTHS ENDED DEC 31,
2022

Source text for Eikon:  ID:nBw6dCB0Na 
Further company coverage:  IMNM.O 

 ((Reuters.Briefs@thomsonreuters.com;))